Mitochondrial involvement in cardiac apoptosis during ischemia and reperfusion: Can we close the box?

Cardiovascular Toxicology

Volumn 9, Issue 4, 2009, Pages 211-227

  Machado, Nuno G ^a   Alves, Marco G ^a,b   Carvalho, Rui A ^a,b   Oliveira, Paulo J ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Apoptosis; Heart; Ischemia; Mitochondria; Reperfusion

Indexed keywords

AMIODARONE; ASCORBIC ACID; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CARNITINE; CARVEDILOL; CYCLOSPORIN A; DIAZOXIDE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXORUBICIN; ENALAPRIL; HO 4038; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; NEBIVOLOL; NICORANDIL; NORPHENAZONE; PIFITHRIN ALPHA; PROPRANOLOL; PROTEIN BAK; PROTEIN BAX; PYRUVIC ACID; SILDENAFIL; SUPEROXIDE DISMUTASE; TRANDOLAPRIL; TRIMETAZIDINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VARDENAFIL; VERAPAMIL DERIVATIVE;

ANTIOXIDANT ACTIVITY; APOPTOSIS; CALCIUM CELL LEVEL; CARDIAC PATIENT; CARDIOTOXICITY; CELL DEATH; CELL DISRUPTION; CELL FUNCTION; CELL LOSS; CELL PROTECTION; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG MECHANISM; ERECTILE DYSFUNCTION; HEART ARRHYTHMIA; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART INJURY; HEART MITOCHONDRION; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART PROTECTION; HUMAN; HYPERTENSION; IMMUNE DEFICIENCY; ISCHEMIC HEART DISEASE; MITOCHONDRIAL PERMEABILITY; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN PROTEIN INTERACTION; REPERFUSION INJURY; REVIEW; SURVIVAL RATE;

ANIMALS; APOPTOSIS; HUMANS; MITOCHONDRIA, HEART; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 71949118545     PISSN: 15307905     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12012-009-9055-1     Document Type: Review

References (175)

1. DJ Hearse 1990 Ischemia, reperfusion, and the determinants of tissue injury Cardiovascular Drugs and Therapy 4 Suppl 4 767 776 2093367
2. CR Holleyman DF Larson 2001 Apoptosis in the ischemic reperfused myocardium Perfusion 16 491 502 11761089
3. N Marczin N El-Habashi GS Hoare RE Bundy M Yacoub 2003 Antioxidants in myocardial ischemia-reperfusion injury: Therapeutic potential and basic mechanisms Archives of Biochemistry and Biophysics 420 222 236 14654061
4. R Ferrari S Curello GM Boffa E Condorelli E Pasini G Guarnieri A Albertini 1989 Oxygen free radical-mediated heart injury in animal models and during bypass surgery in humans. Effects of alpha-tocopherol Annals of the New York Academy of Sciences 570 237 253 2698106
5. G Ambrosio JL Zweier C Duilio P Kuppusamy G Santoro PP Elia I Tritto P Cirillo M Condorelli M Chiariello, et al. 1993 Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow The Journal of Biological Chemistry 268 18532 18541 8395507
6. N Nagy G Malik A Tosaki YS Ho N Maulik DK Das 2008 Overexpression of glutaredoxin-2 reduces myocardial cell death by preventing both apoptosis and necrosis Journal of Molecular and Cellular Cardiology 44 252 260 18076901
7. Z Chen B Siu YS Ho R Vincent CC Chua RC Hamdy BH Chua 1998 Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice Journal of Molecular and Cellular Cardiology 30 2281 2289 9925365
8. G Li Y Chen JT Saari YJ Kang 1997 Catalase-overexpressing transgenic mouse heart is resistant to ischemia-reperfusion injury American Journal of Physiology 273 H1090 H1095 9321793
9. T Yoshida M Watanabe DT Engelman RM Engelman JA Schley N Maulik YS Ho TD Oberley DK Das 1996 Transgenic mice overexpressing glutathione peroxidase are resistant to myocardial ischemia reperfusion injury Journal of Molecular and Cellular Cardiology 28 1759 1767 8877785
10. H Lemieux CL Hoppel 2009 Mitochondria in the human heart Journal of Bioenergetics and Biomembranes 41 99 106 19353253
11. A Riva B Tandler F Loffredo E Vazquez C Hoppel 2005 Structural differences in two biochemically defined populations of cardiac mitochondria American Journal of Physiology Heart and circulatory Physiology 289 H868 H872 15821034
12. JW Palmer B Tandler CL Hoppel 1977 Biochemical properties of subsarcolemmal and interfibrillar mitochondria isolated from rat cardiac muscle The Journal of Biological Chemistry 252 8731 8739 925018
13. JW Palmer B Tandler CL Hoppel 1985 Biochemical differences between subsarcolemmal and interfibrillar mitochondria from rat cardiac muscle: Effects of procedural manipulations Archives of Biochemistry and Biophysics 236 691 702 2982322
14. EJ Lesnefsky TJ Slabe MS Stoll PE Minkler CL Hoppel 2001 Myocardial ischemia selectively depletes cardiolipin in rabbit heart subsarcolemmal mitochondria American Journal of Physiology Heart and Circulatory Physiology 280 H2770 H2778 11356635
15. EJ Lesnefsky B Tandler J Ye TJ Slabe J Turkaly CL Hoppel 1997 Myocardial ischemia decreases oxidative phosphorylation through cytochrome oxidase in subsarcolemmal mitochondria American Journal of Physiology 273 H1544 H1554 9321848
16. J Duan M Karmazyn 1989 Relationship between oxidative phosphorylation and adenine nucleotide translocase activity of two populations of cardiac mitochondria and mechanical recovery of ischemic hearts following reperfusion Canadian Journal of Physiology and Pharmacology 67 704 709 2548694
17. B Loos AM Engelbrecht 2009 Cell death: A dynamic response concept Autophagy 5 590 603 19363298
18. K Mani 2008 Programmed cell death in cardiac myocytes: Strategies to maximize post-ischemic salvage Heart Failure Reviews 13 193 209 18176842
19. Dhesi, P., Tehrani, F., Fuess, J., & Schwarz, E. R. (2009). How does the heart (not) die? The role of autophagy in cardiomyocyte homeostasis and cell death. Heart Failure Reviews, in press.
20. AB Gustafsson RA Gottlieb 2008 Eat your heart out: Role of autophagy in myocardial ischemia/reperfusion Autophagy 4 416 421 18253087
21. A Hamacher-Brady NR Brady RA Gottlieb 2006 The interplay between pro-death and pro-survival signaling pathways in myocardial ischemia/reperfusion injury: apoptosis meets autophagy Cardiovascular Drugs and Therapy 20 445 462 17149555
22. Y Lee AB Gustafsson 2009 Role of apoptosis in cardiovascular disease Apoptosis 14 536 548 19142731
23. S Gupta 2003 Molecular signaling in death receptor and mitochondrial pathways of apoptosis (Review) International Journal of Oncology 22 15 20 12469180
24. CP Baines 2009 The mitochondrial permeability transition pore and ischemia-reperfusion injury Basic Research in Cardiology 104 181 188 19242640
25. SJ Riedl GS Salvesen 2007 The apoptosome: Signalling platform of cell death Nature Reviews Molecular Cell Biology 8 405 413 17377525
26. LM Buja 2005 Myocardial ischemia and reperfusion injury Cardiovascular Pathology 14 170 175 16009313
27. B Freude TN Masters F Robicsek A Fokin S Kostin R Zimmermann C Ullmann S Lorenz-Meyer J Schaper 2000 Apoptosis is initiated by myocardial ischemia and executed during reperfusion Journal of Molecular and Cellular Cardiology 32 197 208 10722797
28. P Lee M Sata DJ Lefer SM Factor K Walsh RN Kitsis 2003 Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo American Journal of Physiology Heart and Circulatory Physiology 284 H456 H463 12414449
29. Z Chen CC Chua YS Ho RC Hamdy BH Chua 2001 Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice American Journal of Physiology Heart and Circulatory Physiology 280 H2313 H2320 11299236
30. S Bialik VL Cryns A Drincic S Miyata AL Wollowick A Srinivasan RN Kitsis 1999 The mitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes Circulation Research 85 403 414 10473670
31. RA Gottlieb KO Burleson RA Kloner BM Babior RL Engler 1994 Reperfusion injury induces apoptosis in rabbit cardiomyocytes Journal of Clinical Investigation 94 1621 1628 7929838
32. ZQ Zhao J Vinten-Johansen 2002 Myocardial apoptosis and ischemic preconditioning Cardiovascular Research 55 438 455 12160941
33. SC Black JQ Huang P Rezaiefar S Radinovic A Eberhart DW Nicholson IW Rodger 1998 Co-localization of the cysteine protease caspase-3 with apoptotic myocytes after in vivo myocardial ischemia and reperfusion in the rat Journal of Molecular and Cellular Cardiology 30 733 742 9602422
34. S Chakrabarti AN Hoque M Karmazyn 1997 A rapid ischemia-induced apoptosis in isolated rat hearts and its attenuation by the sodium-hydrogen exchange inhibitor HOE 642 (cariporide) Journal of Molecular and Cellular Cardiology 29 3169 3174 9405190 (Pubitemid 27510782)
35. V Borutaite A Budriunaite R Morkuniene GC Brown 2001 Release of mitochondrial cytochrome c and activation of cytosolic caspases induced by myocardial ischaemia Biochimica et Biophysica Acta 1537 101 109 11566253
36. V Borutaite A Jekabsone R Morkuniene GC Brown 2003 Inhibition of mitochondrial permeability transition prevents mitochondrial dysfunction, cytochrome c release and apoptosis induced by heart ischemia Journal of Molecular and Cellular Cardiology 35 357 366 12689815
37. K Akiyama TL Gluckman A Terhakopian PM Jinadasa S Narayan S Singaswamy B Massey 3rd RJ Bing 1997 Apoptosis in experimental myocardial infarction in situ and in the perfused heart in vitro Tissue and Cell 29 733 743 9467933
38. ZQ Zhao 2004 Oxidative stress-elicited myocardial apoptosis during reperfusion Current Opinion in Pharmacology 4 159 165 15063360
39. VE Kagan YY Tyurina H Bayir CT Chu AA Kapralov II Vlasova NA Belikova VA Tyurin A Amoscato M Epperly J Greenberger S Dekosky AA Shvedova J Jiang 2006 The "pro-apoptotic genies" get out of mitochondria: Oxidative lipidomics and redox activity of cytochrome c/cardiolipin complexes Chemico Biological Interactions 163 15 28 16797512
40. J St-Pierre MD Brand RG Boutilier 2000 Mitochondria as ATP consumers: Cellular treason in anoxia Proceedings of the National Academy of Sciences of the United States of America 97 8670 8674 10890886
41. Q Chen S Moghaddas CL Hoppel EJ Lesnefsky 2008 Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria American Journal of Physiology Cell Physiology 294 C460 C466 18077608
42. AY Andreyev YE Kushnareva AA Starkov 2005 Mitochondrial metabolism of reactive oxygen species Biochemistry (Mosc) 70 200 214
43. R Ferrari C Ceconi S Curello A Cargnoni F De Giuli O Visioli 1992 Occurrence of oxidative stress during myocardial reperfusion Molecular and Cellular Biochemistry 111 61 69 1588944
44. NS Dhalla AB Elmoselhi T Hata N Makino 2000 Status of myocardial antioxidants in ischemia-reperfusion injury Cardiovascular Research 47 446 456 10963718
45. R Ferrari G Guardigli D Mele GF Percoco C Ceconi S Curello 2004 Oxidative stress during myocardial ischaemia and heart failure Current Pharmaceutical Design 10 1699 1711 15134567
46. SK Powers Z Murlasits M Wu AN Kavazis 2007 Ischemia-reperfusion-induced cardiac injury: A brief review Medicine and Science in Sports and Exercise 39 1529 1536 17805085
47. AP Halestrap 2009 What is the mitochondrial permeability transition pore? Journal of Molecular and Cellular Cardiology 46 821 831 19265700
48. N Zamzami P Marchetti M Castedo T Hirsch SA Susin B Masse G Kroemer 1996 Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis FEBS Letters 384 53 57 8797802
49. VP Skulachev 2000 How proapoptotic proteins can escape from mitochondria? Free Radical Biology and Medicine 29 1056 1059
50. V Borutaite GC Brown 2003 Mitochondria in apoptosis of ischemic heart FEBS Letters 541 1 5 12706809
51. CP Baines 2009 The molecular composition of the mitochondrial permeability transition pore Journal of Molecular and Cellular Cardiology 46 850 857 19233198
52. S Javadov M Karmazyn 2007 Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection Cellular Physiology and Biochemistry 20 1 22 17595511
53. JS Kim L He JJ Lemasters 2003 Mitochondrial permeability transition: A common pathway to necrosis and apoptosis Biochemical and Biophysical Research Communications 304 463 470 12729580
54. 2+ and the heart Cell Calcium 44 77 91 18178248
55. Z Dong P Saikumar JM Weinberg MA Venkatachalam 2006 Calcium in cell injury and death Annu Rev Pathol 1 405 434 18039121
56. M Chen DJ Won S Krajewski RA Gottlieb 2002 Calpain and mitochondria in ischemia/reperfusion injury The Journal of Biological Chemistry 277 29181 29186 12042324
57. SA Novgorodov TI Gudz 2009 Ceramide and mitochondria in ischemia/reperfusion Journal of Cardiovascular Pharmacology 53 198 208 19247196
58. AV Vaseva UM Moll 2009 The mitochondrial p53 pathway Biochimica et Biophysica Acta 1787 414 420 19007744
59. ND Marchenko A Zaika UM Moll 2000 Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling The Journal of Biological Chemistry 275 16202 16212 10821866
60. S Erster M Mihara RH Kim O Petrenko UM Moll 2004 In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation Molecular and Cellular Biology 24 6728 6741 15254240
61. BS Park YS Song SB Yee BG Lee SY Seo YC Park JM Kim HM Kim YH Yoo 2005 Phospho-ser 15-p53 translocates into mitochondria and interacts with Bcl-2 and Bcl-xL in eugenol-induced apoptosis Apoptosis 10 193 200 15711935
62. M Mihara S Erster A Zaika O Petrenko T Chittenden P Pancoska UM Moll 2003 p53 has a direct apoptogenic role at the mitochondria Molecular Cell 11 577 590 12667443
63. KA Webster DJ Discher S Kaiser O Hernandez B Sato NH Bishopric 1999 Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53 Journal of Clinical Investigation 104 239 252 10430605
64. MM Mocanu DM Yellon 2003 p53 down-regulation: A new molecular mechanism involved in ischaemic preconditioning FEBS Letters 555 302 306 14644432
65. P Liu B Xu TA Cavalieri CE Hock 2008 Inhibition of p53 by pifithrin-alpha reduces myocyte apoptosis and leukocyte transmigration in aged rat hearts following 24 hours of reperfusion Shock 30 545 551 18317410
66. A Toth JR Jeffers P Nickson JY Min JP Morgan GP Zambetti P Erhardt 2006 Targeted deletion of Puma attenuates cardiomyocyte death and improves cardiac function during ischemia-reperfusion American Journal of Physiology Heart and Circulatory Physiology 291 H52 H60 16399862
67. JM Adams S Cory 2007 Bcl-2-regulated apoptosis: Mechanism and therapeutic potential Current Opinion in Immunology 19 488 496 17629468
68. JE Chipuk U Maurer DR Green M Schuler 2003 Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription Cancer Cell 4 371 381 14667504
69. D Kumar BI Jugdutt 2003 Apoptosis and oxidants in the heart Journal of Laboratory and Clinical Medicine 142 288 297 14647032
70. T Kuwana MR Mackey G Perkins MH Ellisman M Latterich R Schneiter DR Green DD Newmeyer 2002 Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane Cell 111 331 342 12419244
71. AB Gustafsson RA Gottlieb 2007 Bcl-2 family members and apoptosis, taken to heart American Journal of Physiology Cell Physiology 292 C45 C51 16943242
72. L Zhu Y Yu BH Chua YS Ho TH Kuo 2001 Regulation of sodium-calcium exchange and mitochondrial energetics by Bcl-2 in the heart of transgenic mice Journal of Molecular and Cellular Cardiology 33 2135 2144 11735260
73. M Capano M Crompton 2006 Bax translocates to mitochondria of heart cells during simulated ischaemia: involvement of AMP-activated and p38 mitogen-activated protein kinases Biochemical Journal 395 57 64 16321138
74. LA Kirshenbaum D de Moissac 1997 The bcl-2 gene product prevents programmed cell death of ventricular myocytes Circulation 96 1580 1585 9315550
75. V Brocheriou AA Hagege A Oubenaissa M Lambert VO Mallet M Duriez M Wassef A Kahn P Menasche H Gilgenkrantz 2000 Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury The Journal of Gene Medicine 2 326 333 11045426
76. N Weisleder GE Taffet Y Capetanaki 2004 Bcl-2 overexpression corrects mitochondrial defects and ameliorates inherited desmin null cardiomyopathy Proceedings of the National Academy of Sciences of the United States of America 101 769 774 14715896
77. GJ Grover PA Marone L Koetzner D Seto-Young 2008 Energetic signalling in the control of mitochondrial F1F0 ATP synthase activity in health and disease International Journal of Biochemistry and Cell Biology 40 2698 2701 18707016
78. JB Classen WJ Mergner M Costa 1989 ATP hydrolysis by ischemic mitochondria Journal of Cellular Physiology 141 53 59 2777902
79. K Imahashi MD Schneider C Steenbergen E Murphy 2004 Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury Circulation Research 95 734 741 15345651
80. N Maulik RM Engelman JA Rousou JE Flack 3rd D Deaton DK Das 1999 Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2 Circulation 100 II369 II375 10567332
81. R Hattori TE Hernandez L Zhu N Maulik H Otani Y Kaneda DK Das 2001 An essential role of the antioxidant gene Bcl-2 in myocardial adaptation to ischemia: an insight with antisense Bcl-2 therapy Antioxidants & Redox Signaling 3 403 413
82. DC Wallace JM Shoffner I Trounce MD Brown SW Ballinger M Corral-Debrinski T Horton AS Jun MT Lott 1995 Mitochondrial DNA mutations in human degenerative diseases and aging Biochimica et Biophysica Acta 1271 141 151 7599200
83. T Yasuda H Kamiya Y Tanaka G Watanabe 2001 Ultra-short-acting cardioselective beta-blockade attenuates postischemic cardiac dysfunction in the isolated rat heart European Journal of Cardio-Thoracic Surgery 19 647 652 11343946
84. HN Sabbah 1999 The cellular and physiologic effects of beta blockers in heart failure Clinical Cardiology 22 Suppl 5 V16 V20 10526699
85. K Kawai F Qin J Shite W Mao S Fukuoka CS Liang 2004 Importance of antioxidant and antiapoptotic effects of beta-receptor blockers in heart failure therapy American Journal of Physiology Heart and Circulatory Physiology 287 H1003 H1012 15105169
86. WG Nayler R Ferrari A Williams 1980 Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium American Journal of Cardiology 46 242 248 7405836
87. G Vandeplassche HR Lu L Wouters W Flameng M Borgers 1991 Normothermic ischemic cardiac arrest in the isolated working rabbit heart: effects of dl-nebivolol and atenolol Basic Research in Cardiology 86 21 31 1673598
88. RS Carreira P Monteiro LM Gon Alves LA Providencia 2006 Carvedilol: Just another Beta-blocker or a powerful cardioprotector? Cardiovascular & Hematological Disorders Drug Targets 6 257 266
89. PJ Oliveira L Goncalves P Monteiro LA Providencia AJ Moreno 2005 Are the antioxidant properties of carvedilol important for the protection of cardiac mitochondria? Current Vascular Pharmacology 3 147 158 15853634
90. TL Yue HY Cheng PG Lysko PJ McKenna R Feuerstein JL Gu KA Lysko LL Davis G Feuerstein 1992 Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger Journal of Pharmacology and Experimental Therapeutics 263 92 98 1357162
91. TL Yue PJ McKenna RR Ruffolo Jr G Feuerstein 1992 Carvedilol, a new beta-adrenoceptor antagonist and vasodilator antihypertensive drug, inhibits superoxide release from human neutrophils European Journal of Pharmacology 214 277 280 1355437
92. P Spallarossa S Garibaldi P Altieri P Fabbi V Manca S Nasti P Rossettin G Ghigliotti A Ballestrero F Patrone A Barsotti C Brunelli 2004 Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro Journal of Molecular and Cellular Cardiology 37 837 846 15380674
93. G Feuerstein TL Yue X Ma RR Ruffolo 1998 Novel mechanisms in the treatment of heart failure: Inhibition of oxygen radicals and apoptosis by carvedilol Progress in Cardiovascular Diseases 41 17 24 9715819
94. PJ Oliveira T Esteves AP Rolo CM Palmeira AJ Moreno 2004 Carvedilol inhibits the mitochondrial permeability transition by an antioxidant mechanism Cardiovascular Toxicology 4 11 20 15034201
95. PJ Oliveira JA Bjork MS Santos RL Leino MK Froberg AJ Moreno KB Wallace 2004 Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity Toxicology and Applied Pharmacology 200 159 168 15476868
96. P Sgobbo C Pacelli I Grattagliano G Villani T Cocco 2007 Carvedilol inhibits mitochondrial complex I and induces resistance to H2O2 -mediated oxidative insult in H9C2 myocardial cells Biochimica et Biophysica Acta 1767 222 232 17346667
97. N Noguchi K Nishino E Niki 2000 Antioxidant action of the antihypertensive drug, carvedilol, against lipid peroxidation Biochemical Pharmacology 59 1069 1076 10704936
98. PJ Oliveira PM Coxito AP Rolo DL Santos CM Palmeira AJ Moreno 2001 Inhibitory effect of carvedilol in the high-conductance state of the mitochondrial permeability transition pore European Journal of Pharmacology 412 231 237 11166286
99. PJ Oliveira AP Rolo CM Palmeira AJ Moreno 2001 Carvedilol reduces mitochondrial damage induced by hypoxanthine/xanthine oxidase: Relevance to hypoxia/reoxygenation injury Cardiovascular Toxicology 1 205 213 12213973
100. PJ Oliveira DJ Santos AJ Moreno 2000 Carvedilol inhibits the exogenous NADH dehydrogenase in rat heart mitochondria Archives of Biochemistry and Biophysics 374 279 285 10666308
101. H Nohl 1987 Demonstration of the existence of an organo-specific NADH dehydrogenase in heart mitochondria European Journal of Biochemistry 169 585 591 3691507
102. PJ Oliveira MP Marques LA Batista de Carvalho AJ Moreno 2000 Effects of carvedilol on isolated heart mitochondria: Evidence for a protonophoretic mechanism Biochemical and Biophysical Research Communications 276 82 87 11006086
103. T Kristian BK Siesjo 1998 Calcium in ischemic cell death Stroke 29 705 718 9506616
104. R Ferrari O Visioli 1991 Calcium channel blockers and ischaemic heart disease: Theoretical expectations and clinical experience European Heart Journal 12 Suppl F 18 24 1804637
105. IK Mohan M Khan S Wisel K Selvendiran A Sridhar CA Carnes B Bognar T Kalai K Hideg P Kuppusamy 2009 Cardioprotection by HO-4038, a novel verapamil derivative, targeted against ischemia and reperfusion-mediated acute myocardial infarction American journal of Physiology Heart and Circulatory Physiology 296 H140 H151 18978191
106. MA Matlib KL McFarland 1991 Diltiazem inhibition of sodium-induced calcium release. Effects on energy metabolism of heart mitochondria American Journal of Hypertension 4 435S 441S 1910637
107. L Tabouy AM Chauvet-Monges MD Salducci A Crevat 1994 Protective effect of some calcium antagonists against mitochondrial calcium injury International Journal of Tissue Reactions 16 221 228 7558666
108. H Vavrinkova M Tutterova P Stopka J Divisova L Kazdova Z Drahota 2001 The effect of captopril on nitric oxide formation and on generation of radical forms of mitochondrial respiratory chain compounds in ischemic rat heart Physiological Research 50 481 489 11702852
109. T Yanagishita M Tomita S Itoh S Mukae H Arata H Ishioka E Geshi N Konno T Katagiri 1997 Protective effect of captopril on ischemic myocardium Japanese Circulation Journal 61 161 169 9070972
110. A Sanbe K Tanonaka R Kobayasi S Takeo 1995 Effects of long-term therapy with ACE inhibitors, captopril, enalapril and trandolapril, on myocardial energy metabolism in rats with heart failure following myocardial infarction Journal of Molecular and Cellular Cardiology 27 2209 2222 8576937
111. P Monteiro PJ Oliveira L Concalves LA Providencia 2003 Pharmacological modulation of mitochondrial function during ischemia and reperfusion Revista Portuguesa de Cardiologia 22 407 429 12847881
112. K Swedberg P Held J Kjekshus K Rasmussen L Ryden H Wedel 1992 Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) New England Journal of Medicine 327 678 684 1495520
113. P Monteiro AI Duarte LM Goncalves LA Providencia 2005 Valsartan improves mitochondrial function in hearts submitted to acute ischemia European Journal of Pharmacology 518 158 164 16055115
114. BN Singh 2006 Amiodarone: A multifaceted antiarrhythmic drug Current Cardiology Reports 8 349 355 16956450
115. G Varbiro A Toth A Tapodi B Veres B Sumegi F Gallyas Jr 2003 Concentration dependent mitochondrial effect of amiodarone Biochemical Pharmacology 65 1115 1128 12663047
116. M Spedding JP Tillement D Morin A Le Ridant 1999 Medicines interacting with mitochondria: Anti-ischemic effects of trimetazidine Therapie 54 627 635 10667101
117. PF Kantor A Lucien R Kozak GD Lopaschuk 2000 The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase Circulation Research 86 580 588 10720420
118. A Grynberg L Demaison 1996 Fatty acid oxidation in the heart Journal of Cardiovascular Pharmacology 28 Suppl 1 S11 S17 8891866
119. D Morin T Hauet M Spedding J Tillement 2001 Mitochondria as target for antiischemic drugs Advanced Drug Delivery Reviews 49 151 174 11377809
120. C Guarnieri C Finelli M Zini C Muscari 1997 Effects of trimetazidine on the calcium transport and oxidative phosphorylation of isolated rat heart mitochondria Basic Research in Cardiology 92 90 95 9166988
121. K Veitch L Maisin L Hue 1995 Trimetazidine effects on the damage to mitochondrial functions caused by ischemia and reperfusion American Journal of Cardiology 76 25B 30B 7645524
122. FN Salloum RA Ockaili M Wittkamp VR Marwaha RC Kukreja 2006 Vardenafil: a novel type 5 phosphodiesterase inhibitor reduces myocardial infarct size following ischemia/reperfusion injury via opening of mitochondrial K(ATP) channels in rabbits Journal of Molecular and Cellular Cardiology 40 405 411 16480739
123. RC Kukreja F Salloum A Das R Ockaili C Yin YA Bremer PW Fisher M Wittkamp J Hawkins E Chou AK Kukreja X Wang VR Marwaha L Xi 2005 Pharmacological preconditioning with sildenafil: Basic mechanisms and clinical implications Vascular Pharmacology 42 219 232 15922255
124. FN Salloum Y Takenoshita RA Ockaili VP Daoud E Chou K Yoshida RC Kukreja 2007 Sildenafil and vardenafil but not nitroglycerin limit myocardial infarction through opening of mitochondrial K(ATP) channels when administered at reperfusion following ischemia in rabbits Journal of Molecular and Cellular Cardiology 42 453 458 17157308
125. MA Fernandes RJ Marques JA Vicente MS Santos P Monteiro AJ Moreno JB Custodio 2008 Sildenafil citrate concentrations not affecting oxidative phosphorylation depress H2O2 generation by rat heart mitochondria Molecular and Cellular Biochemistry 309 77 85 18026820
126. + channels in sildenafil-induced late cardioprotection Journal of Molecular and Cellular Cardiology 44 105 113 18021798
127. T Reffelmann RA Kloner 2005 Pharmacotherapy of erectile dysfunction: Focus on cardiovascular safety Expert Opinion on Drug Safety 4 531 540 15934858
128. + channels. Possible mechanism of cardioprotection Circulation Research 81 1072 1082 9400389
129. CP Baines GS Liu M Birincioglu SD Critz MV Cohen JM Downey 1999 Ischemic preconditioning depends on interaction between mitochondrial KATP channels and actin cytoskeleton American Journal of Physiology 276 H1361 H1368 10199863
130. E Takashi Y Wang M Ashraf 1999 Activation of mitochondrial K(ATP) channel elicits late preconditioning against myocardial infarction via protein kinase C signaling pathway Circulation Research 85 1146 1153 10590241
131. P Pasdois B Beauvoit L Tariosse B Vinassa S Bonoron-Adele P Dos Santos 2008 Effect of diazoxide on flavoprotein oxidation and reactive oxygen species generation during ischemia-reperfusion: A study on Langendorff-perfused rat hearts using optic fibers American Journal of Physiology Heart and Circulatory Physiology 294 H2088 H2097 18296562
132. Y Ohnuma T Miura T Miki M Tanno A Kuno A Tsuchida K Shimamoto 2002 Opening of mitochondrial K(ATP) channel occurs downstream of PKC-epsilon activation in the mechanism of preconditioning American Journal of Physiology Heart and Circulatory Physiology 283 H440 H447 12063319
133. P Korge HM Honda JN Weiss 2002 Protection of cardiac mitochondria by diazoxide and protein kinase C: Implications for ischemic preconditioning Proceedings of the National Academy of Sciences of the United States of America 99 3312 3317 11867760
134. S Minatoguchi N Wang Y Uno M Arai K Hashimoto Y Hashimoto XH Chen G Takemura H Fujiwara 2001 Combination of miglitol, an anti-diabetic drug, and nicorandil markedly reduces myocardial infarct size through opening the mitochondrial K(ATP) channels in rabbits British Journal of Pharmacology 133 1041 1046 11487514
135. C Ozcan M Bienengraeber PP Dzeja A Terzic 2002 Potassium channel openers protect cardiac mitochondria by attenuating oxidant stress at reoxygenation American Journal of Physiology Heart and Circulatory Physiology 282 H531 H539 11788400
136. T Iwai K Tanonaka K Motegi R Inoue S Kasahara S Takeo 2002 Nicorandil preserves mitochondrial function during ischemia in perfused rat heart European Journal of Pharmacology 446 119 127 12098593 (Pubitemid 34722565)
137. T Sato N Sasaki B O'Rourke E Marban 2000 Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels Journal of the American College of Cardiology 35 514 518 10676702
138. AP Halestrap P Pasdois 2009 The role of the mitochondrial permeability transition pore in heart disease Biochimica et Biophysica Acta 1787 1402 1415 19168026
139. AP Halestrap AM Davidson 1990 Inhibition of Ca2(+)-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase Biochemical Journal 268 153 160 2160810
140. AP Halestrap SJ Clarke SA Javadov 2004 Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection Cardiovascular Research 61 372 385 14962470
141. CP Baines RA Kaiser NH Purcell NS Blair H Osinska MA Hambleton EW Brunskill MR Sayen RA Gottlieb GW Dorn J Robbins JD Molkentin 2005 Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death Nature 434 658 662 15800627
142. T Nakagawa S Shimizu T Watanabe O Yamaguchi K Otsu H Yamagata H Inohara T Kubo Y Tsujimoto 2005 Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death Nature 434 652 658 15800626
143. AP Halestrap CP Connern EJ Griffiths PM Kerr 1997 Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury Molecular and Cellular Biochemistry 174 167 172 9309682
144. A Magnasco A Rossi P Catarsi R Gusmano F Ginevri F Perfumo GM Ghiggeri 2008 Cyclosporin and organ specific toxicity: Clinical aspects, pharmacogenetics and perspectives Current Clinical Pharmacology 3 166 173 18781903
145. R Ferrari E Merli G Cicchitelli D Mele A Fucili C Ceconi 2004 Therapeutic effects of l-carnitine and propionyl-l-carnitine on cardiovascular diseases: A review Annals of the New York Academy of Sciences 1033 79 91 15591005
146. N Andrieu-Abadie JP Jaffrezou S Hatem G Laurent T Levade JJ Mercadier 1999 l-carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: Role of inhibition of ceramide generation Faseb Journal 13 1501 1510 10463940
147. MC Mutomba H Yuan M Konyavko S Adachi CB Yokoyama V Esser JD McGarry BM Babior RA Gottlieb 2000 Regulation of the activity of caspases by l-carnitine and palmitoylcarnitine FEBS Letters 478 19 25 10922462
148. L Gao K Laude H Cai 2008 Mitochondrial pathophysiology, reactive oxygen species, and cardiovascular diseases Veterinary Clinics of North America Small Animal Practice 38 137 155
149. M Yamawaki N Sasaki M Shimoyama J Miake K Ogino O Igawa F Tajima C Shigemasa I Hisatome 2004 Protective effect of edaravone against hypoxia-reoxygenation injury in rabbit cardiomyocytes British Journal of Pharmacology 142 618 626 15148265
150. T Watanabe S Yuki M Egawa H Nishi 1994 Protective effects of MCI-186 on cerebral ischemia: Possible involvement of free radical scavenging and antioxidant actions Journal of Pharmacology and Experimental Therapeutics 268 1597 1604 8138971
151. KG Rajesh S Sasaguri R Suzuki H Maeda 2003 Antioxidant MCI-186 inhibits
152. K Yamazaki S Miwa S Toyokuni S Nemoto W Oriyanhan K Takaba Y Saji A Marui T Nishina T Ikeda M Komeda 2009 Effect of edaravone, a novel free radical scavenger, supplemented to cardioplegia on myocardial function after cardioplegic arrest: in vitro study of isolated rat heart Heart and Vessels 24 228 235 19466525
153. RT Mallet J Sun EM Knott AB Sharma AH Olivencia-Yurvati 2005 Metabolic cardioprotection by pyruvate: Recent progress Experimental Biology and Medicine (Maywood) 230 435 443
154. RT Mallet J Sun 1999 Mitochondrial metabolism of pyruvate is required for its enhancement of cardiac function and energetics Cardiovascular Research 42 149 161 10435006
155. PM Kerr MS Suleiman AP Halestrap 1999 Reversal of permeability transition during recovery of hearts from ischemia and its enhancement by pyruvate American Journal of Physiology 276 H496 H502 9950850
156. KL Hamilton 2007 Antioxidants and cardioprotection Medicine and Science in Sports and Exercise 39 1544 1553 17805087
157. T Pain XM Yang SD Critz Y Yue A Nakano GS Liu G Heusch MV Cohen JM Downey 2000 Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals Circulation Research 87 460 466 10988237
158. VJ Adlam JC Harrison CM Porteous AM James RA Smith MP Murphy IA Sammut 2005 Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury Faseb Journal 19 1088 1095 15985532
159. LE Bakeeva IV Barskov MV Egorov NK Isaev VI Kapelko AV Kazachenko VI Kirpatovsky SV Kozlovsky VL Lakomkin SB Levina OI Pisarenko EY Plotnikov VB Saprunova LI Serebryakova MV Skulachev EV Stelmashook IM Studneva OV Tskitishvili AK Vasilyeva IV Victorov DB Zorov VP Skulachev 2008 Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 2. Treatment of some ROS- and age-related diseases (heart arrhythmia, heart infarctions, kidney ischemia, and stroke) Biochemistry (Mosc) 73 1288 1299
160. MP Fink CA Macias J Xiao YY Tyurina RL Delude JS Greenberger VE Kagan P Wipf 2007 Hemigramicidin-TEMPO conjugates: novel mitochondria-targeted antioxidants Critical Care Medicine 35 S461 S467 17713394
161. AM James HM Cocheme MP Murphy 2005 Mitochondria-targeted redox probes as tools in the study of oxidative damage and ageing Mechanisms of Ageing and Development 126 982 986 15923020
162. CG Giacomo M Antonio 2007 Melatonin in cardiac ischemia/reperfusion- induced mitochondrial adaptive changes Cardiovascular Hematological Disorders Drug Targets 7 163 169 17896956
163. D Acuna-Castroviejo G Escames MI Rodriguez LC Lopez 2007 Melatonin role in the mitochondrial function Front Bioscience 12 947 963
164. H Ceyran F Narin N Narin H Akgun AB Ceyran F Ozturk Y Akcali 2008 The effect of high dose melatonin on cardiac ischemia- reperfusion injury Yonsei Medical Journal 49 735 741 18972593
165. G Petrosillo N Di Venosa M Pistolese G Casanova E Tiravanti G Colantuono A Federici G Paradies FM Ruggiero 2006 Protective effect of melatonin against mitochondrial dysfunction associated with cardiac ischemia- reperfusion: Role of cardiolipin Faseb Journal 20 269 276 16449799
166. B Ostadal I Netuka J Maly J Besik I Ostadalova 2009 Gender differences in cardiac ischemic injury and protection-experimental aspects Experimental Biology and Medicine (Maywood) 234 1011 1019
167. EA Booth BR Lucchesi 2008 Estrogen-mediated protection in myocardial ischemia-reperfusion injury Cardiovascular Toxicology 8 101 113 18683081
168. Y Xu IA Arenas SJ Armstrong WC Plahta H Xu ST Davidge 2006 Estrogen improves cardiac recovery after ischemia/reperfusion by decreasing tumor necrosis factor-alpha Cardiovascular Research 69 836 844 16403479
169. SP Duckles DN Krause C Stirone V Procaccio 2006 Estrogen and mitochondria: A new paradigm for vascular protection? Molecular Interventions 6 26 35 16507748
170. R Morkuniene A Jekabsone V Borutaite 2002 Estrogens prevent calcium-induced release of cytochrome c from heart mitochondria FEBS Letters 521 53 56 12067725
171. SH Yang R Liu EJ Perez Y Wen SM Stevens Jr T Valencia AM Brun-Zinkernagel L Prokai Y Will J Dykens P Koulen JW Simpkins 2004 Mitochondrial localization of estrogen receptor beta Proceedings of the National Academy of Sciences of the United States of America 101 4130 4135 15024130
172. R Morkuniene O Arandarcikaite V Borutaite 2006 Estradiol prevents release of cytochrome c from mitochondria and inhibits ischemia-induced apoptosis in perfused heart Experimental Gerontology 41 704 708 16580805
173. 2+]i during metabolic inhibition Journal of Molecular and Cellular Cardiology 35 331 336 12676548
174. QD Wang J Pernow PO Sjoquist L Ryden 2002 Pharmacological possibilities for protection against myocardial reperfusion injury Cardiovascular Research 55 25 37 12062706
175. JM Berthiaume PJ Oliveira MW Fariss KB Wallace 2005 Dietary vitamin E decreases doxorubicin-induced oxidative stress without preventing mitochondrial dysfunction Cardiovascular Toxicology 5 257 267 16244371